XML 44 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE
12 Months Ended
Dec. 31, 2017
Fair Value Disclosures [Abstract]  
FAIR VALUE
FAIR VALUE
The following table provides a summary of fair value assets and liabilities as of December 31, 2017 measured at fair value on a recurring basis:
Description
 
Balance as of December 31, 2017
 
Quoted Prices in
Active Markets for
Identical Assets or
Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs (Level 3)
Assets:
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
2,776

 
$

 
$
2,776

 
$

Marketable securities
 
179,125

 

 
179,125

 

Total assets
 
$
181,901

 
$

 
$
181,901

 
$

Liabilities:
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
4,351

 
$

 
$
4,351

 
$

Interest rate swap agreements
 
5,085

 

 
5,085

 

Contingent considerations
 
7,086

 

 

 
7,086

Deferred compensation
 
25,397

 

 
25,397

 

Total liabilities
 
$
41,919

 
$

 
$
34,833

 
$
7,086

The following table provides a summary of fair value assets and liabilities as of December 31, 2016 measured at fair value on a recurring basis:
Description
 
Balance as of December 31, 2016
 
Quoted Prices in
Active Markets for
Identical Assets or
Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs (Level 3)
Assets:
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
1,185

 
$

 
$
1,185

 
$

Marketable securities
 
38,922

 

 
38,922

 

Total assets
 
$
40,107

 
$

 
$
40,107

 
$

Liabilities:
 
 

 
 

 
 

 
 

Foreign exchange contracts
 
$
2,452

 
$

 
$
2,452

 
$

Interest rate swap agreements
 
5,439

 

 
5,439

 

Contingent considerations
 
8,154

 

 

 
8,154

Forward contract
 
15,272

 

 

 
15,272

Deferred compensation
 
25,244

 

 
25,244

 

Total liabilities
 
$
56,561

 
$

 
$
33,135

 
$
23,426


The Company's derivative contracts are valued at fair value using the market approach. The Company measures the fair value of foreign exchange contracts and interest rate swap agreements using Level 2 inputs based on observable spot and forward rates in active markets. During the year ended December 31, 2017, there were no transfers between Levels 1, 2 or 3.
The Company measures the fair value of marketable securities using Level 2 inputs based on quoted market prices for similar assets in active markets.
In connection with acquisitions, the Company recorded contingent considerations fair valued at $7,086 as of December 31, 2017. Under the contingent consideration agreements the amounts to be paid are based upon actual financial results of the acquired entity for specified future periods. The fair value of the contingent considerations are a Level 3 valuation and fair valued using either a probability weighted discounted cash flow analysis or an option pricing model.
In connection with an acquisition, the Company obtained a controlling financial interest in the acquired entity and at the same time entered into a forward contract to obtain the remaining financial interest in the entity over a three-year period. The final payment associated with the forward contract was paid by the Company in the second quarter of 2017.
The deferred compensation liability is the Company’s obligation under its executive deferred compensation plan.  The Company measures the fair value of the liability using the market values of the participants’ underlying investment fund elections.
The Company has various financial instruments, including cash and cash equivalents, short and long-term debt and forward contracts. While these financial instruments are subject to concentrations of credit risk, the Company has minimized this risk by entering into arrangements with a number of major banks and financial institutions and investing in several high-quality instruments. The Company does not expect any counterparties to fail to meet their obligations. The fair value of Cash and cash equivalents, Accounts receivable, Amounts due banks and Trade accounts payable approximated book value due to the short-term nature of these instruments at both December 31, 2017 and December 31, 2016. Refer to Note 8 to the consolidated financial statements for the fair value estimate of debt.